RESEARCH MONOGRAPH · KDC-MN-163

Theobromine

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

71/100

Caffeine's gentler cousin, real cardiovascular effects, weirdly underused as a research compound

Theobromine is the dominant methylxanthine in cocoa, structurally similar to caffeine but missing one methyl group (3,7-dimethylxanthine vs caffeine's 1,3,7-trimethylxanthine). That one methyl group does a lot of work in terms of receptor affinity and metabolism.

Mechanism is the same family: adenosine A1 and A2A antagonism, but with maybe a tenth to a quarter the affinity of caffeine at A2A. Phosphodiesterase inhibition is similar in potency. The half-life is longer than caffeine (7-12 hours vs 5 hours) but the CNS punch is much smaller, which is why you can eat a lot of dark chocolate without feeling wired the way an equivalent caffeine dose would feel.

The interesting pharmacology is peripheral. Theobromine is a clinically meaningful vasodilator (more so than caffeine), a mild diuretic, and a smooth-muscle relaxant in airways. There's a small but consistent literature showing blood pressure reduction at 500-1000mg doses, which is opposite to what you'd expect from caffeine. Some of the cocoa cardiovascular benefit literature is probably theobromine doing real work alongside the flavanols.

Cough work is genuinely interesting too. There were small trials in the 2000s showing theobromine suppressing cough via vagal afferent modulation, with effects comparable to codeine and a better side effect profile. That work mostly didnt move forward into Phase 3 development for reasons that are more commercial than pharmacological.

Sourcing-wise theobromine is widely available as bulk material, easy to synthesize, HPLC verification is standard. The thing to watch is that some pharmacy-grade material has trace caffeine contamination from the cocoa-derived isolation route, which matters if you're trying to isolate theobromine-specific effects.

Safety profile is clean in humans, dangerous in dogs (theyre slow metabolizers, which is the chocolate toxicity story).

What we like: it's the gentler methylxanthine with a real cardiovascular signal that doesnt get the attention it deserves. The cough work is intriguing. What we dont like: it's been treated as a footnote next to caffeine for so long that the research budget is tiny relative to what the mechanism deserves.

Underused as a research tool, honestly.

Evidence: 62
Mechanism: 78
Reliability: 70
Safety: 80
Sourcing: 78
Value: 75
Signal: 60
Staying power: 70

Plain-language summary Intrigue 45 / 100

Theobromine is the principal alkaloid of cocoa and chocolate. It is structurally similar to caffeine but with weaker stimulant effects and longer duration. The compound is highly toxic to dogs but not humans. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Methylxanthine

The principal methylxanthine in cacao with milder CNS effects than caffeine and stronger peripheral vasodilation.

Abstract

Theobromine (3,7-dimethylxanthine; CAS 83-67-0) is the principal methylxanthine in cacao (Theobroma cacao), with smaller amounts in tea. The compound has milder CNS effects than caffeine but stronger peripheral cardiovascular effects (vasodilation, modest blood pressure reduction). Mechanism is the same general class as caffeine (adenosine antagonism, PDE inhibition) but with different relative potencies at the various adenosine receptor subtypes. Pharmacokinetics: plasma half-life 7 to 12 hours (longer than caffeine). Reported research dose ranges in the literature span 200 to 700 mg from supplements or chocolate. The compound is also notable for toxicity in dogs and other non-human mammals due to slower metabolism.

Mechanism of action

Adenosine antagonist; milder CNS effects than caffeine, stronger peripheral vasodilation.

Reported research dose ranges

Reported research dose ranges in the literature span 200 to 700 mg from supplements.

References

Smit HJ. Theobromine and the pharmacology of cocoa. Handb Exp Pharmacol 2011.

Read the full monograph

Available as a research-use-only PDF download. Note: PDFs for newly added compounds may take a few hours to propagate after this article was published.

KDC-MN-163

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Theobromine

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs